US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...

Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...

NEW: Baldwin reveals that NIH has awarded zero grants in 10 days and is failing to fund research projects, including to find ...

Alzheimer’s Research UK funds research into treatment, diagnosis and prevention. Of particular importance is research which has translational potential to benefit people with or at risk of dementia.

Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

It could be as simple as constantly misplacing keys, or forgetting to pay a bill, or repeating questions over and over.

Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.